コモリ コウジ   Komori Kouji
  小森 光二
   所属   東邦大学  医学部 医学科
   職種   助教
論文種別 原著
言語種別 英語
査読の有無 査読なし
表題 A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma
掲載誌名 正式名:Journal of Infection and Chemotherapy
掲載区分国外
出版社 Elsevier {BV}
巻・号・頁 28(8),pp.1212-1215
著者・共著者 Ai Kato,Ayumi Yoshifuji,Kohji Komori,Kotaro Aoki,Daisuke Taniyama,Motoaki Komatsu,Kentaro Fujii,Kuniko Yamada,Yoshikazu Ishii,Takahide Kikuchi,Munekazu Ryuzaki
発行年月 2022/08
概要 A 70-year-old woman, who started on hemodialysis 7 months before for end-stage renal disease due to diabetic nephropathy and was diagnosed with symptomatic multiple myeloma 1 month before, was admitted to our hospital with critical coronavirus disease 2019 and treated with long-term immunosuppressive therapy such as steroids and tocilizumab. During treatment, Bacillus subtilis was detected in the blood cultures. We could not exclude the association of natto (fermented soybeans) with B. subtilis var. natto, which the patient had been eating every day from 8 days after admission. She was prohibited from eating natto and treated with vancomycin. Later, B. subtilis detected in the blood culture was identified as B. subtilis var. natto, which was identical with those contained in the natto that the patient consumed daily using a next-generation sequencer. Gut dysbiosis due to old age, malignant tumor, diabetes mellitus, end-stage renal disease, and intestinal inflammation caused by severe acute respiratory syndrome coronavirus 2 increased intestinal permeability and the risk of bacterial translocation, causing B. subtilis var. natto bacteremia. Therefore, careful consideration might be given to the intake of fermented foods containing live bacteria in patients with severe immunocompromised conditions.
DOI 10.1016/j.jiac.2022.05.006
ORCIDのPut Code 113472856
PMID 35618619